Recently, the State Food and Drug Administration issued an announcement that according to the provisions of the "Measures for the Classification and Management of Prescription Drugs and Over-the-Counter Drugs (Trial)", after the State Food and Drug Administration organized demonstration and review, the pain relief capsules were converted from prescription drugs to over-the-counter drugs
.
The list of varieties and the model instructions for over-the-counter drugs are published
together.
Through the search, it was found that there are two approvals for this variety, and the production enterprises are Yunnan Panlong Yunhai Pharmaceutical Co.
, Ltd.
and Hunan Materia Medica Pharmaceutical Co.
, Ltd.
What is the difference between prescription drugs and over-the-counter drugs? From the perspective of purchase routes, prescription drugs must be prepared by a practicing physician or practicing physician assistant before they can be dispensed, purchased and used; Over-the-counter drugs can be purchased and used
at their own discretion and at pharmacies.
When prescription drugs are converted to over-the-counter drugs (OTC), it is generally conducive to bringing more sales growth to related pharmaceutical companies, and it is also convenient for patients to buy drugs in offline pharmacies and online e-commerce platforms, and can achieve the purpose of
saving national medical insurance funds.
The industry believes that the pain relief capsules are proprietary Chinese medicines, and the product is not transferable, or it is expected to get more sales growth, and it will also be more convenient for patients to buy the drug
in offline pharmacies and online e-commerce platforms.
In addition, the industry combed and found that a total of 40 prescription drugs were converted to over-the-counter drugs in 2020
.
Since 2021, the State Food and Drug Administration has also issued a total of 21 prescription drug to OTC drug announcements, involving 46 kinds of drugs (in terms of product name), including omeprazole enteric-coated tablets, glucosamine sulfate potassium tablets, Baongynkang gel, tonic beauty granules, Pudilan anti-inflammatory tablets, safflower getaway tablets, biphenylacetic acid gel, aloe vera pearl capsules, deficiency quenching agent, ambroxol hydrochloride sustained release tablets, wind relief and detoxification capsules, Jin Zhen granules, gynecological white phoenix capsules, etc
.
The conversion of these prescription drugs to over-the-counter drugs indicates that their safety is reliable and guaranteed
.
It is understood that over-the-counter drugs can be divided into two categories
according to safety.
According to China's "Measures for the Classification and Management of Prescription Drugs and Non-prescription Drugs", although OTC can be purchased in pharmacies, Class B over-the-counter drugs are safer, and Class B drugs can be retailed
in other commercial enterprises (such as cosmetics stores and supermarkets) approved by the provincial drug supervision and administration department or its authorized drug supervision and management department.
In other words, Class B over-the-counter drugs are not limited to pharmacies
.
Class A over-the-counter drugs are recommended to be purchased and used under the guidance of a licensed pharmacist, and only licensed pharmacies can retail Class A over-the-counter drugs to individuals
.
It is worth noting that from the recent conversion of prescription drugs to over-the-counter drugs, mostly proprietary Chinese medicines, proprietary Chinese medicines have obviously become a popular variety
in the OTC market.
Analysts believe that this is mainly because proprietary Chinese medicines have the innate advantage
of "disposing of non-compliance".
On the one hand, due to the support of favorable policies in traditional Chinese medicine, coupled with the intensification of aging and the continuous upgrading of consumption, most people have a strong sense of self-medication for common diseases; On the other hand, most people prefer to take it by themselves through convenient purchase in pharmacies, resulting in proprietary Chinese medicine OTC being more easily accepted
by the market.
In the future, for relevant pharmaceutical companies, as proprietary Chinese medicines continue to be included in the "transfer of non-treatment", it is expected to directly reach more consumers, increase product sales, and use more flexible promotion and sales methods to expand market share
.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.
